News and Press Releases
Press releases
Theralase Granted US Patent for Lead Anti-Cancer Drug
Press ReleaseToronto, Ontario – June 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the deve...
Theralase Signs Clinical Research Agreement with University Health Network
Press ReleaseToronto, Ontario – May 12, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the devel...
Theralase Presents Anti-Cancer Technology at 111th Annual American Urological Association Meeting
Press ReleaseToronto, Ontario – May 11, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the devel...
Theralase Increases Revenue 40% in 2015 Financials
Press ReleaseToronto, Ontario – April 29, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on commercializing medical devices to eliminate pain and developing Photo D...
Theralase Achieves Stability Milestone of Lead Anti-Cancer Drug
Press ReleaseToronto, Ontario – April 22, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on commercialization of medical devices to eliminate pain and development o...
Theralase Research Published in International Peer-Reviewed Journal
Press ReleaseToronto, Ontario – April 15, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and de...
Theralase Provides Update on 2016 Strategic Initiatives
Press ReleaseToronto, Ontario – March 18, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and de...
Theralase Debuts Next Generation Therapeutic Laser in US
Press ReleaseToronto, Ontario – January 14, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and ...
Theralase to Present at Noble Investor Conference
Press ReleaseToronto, Ontario – January 13, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and ...
Theralase to Present at AlphaNorth Capital Conference
Press ReleaseToronto, Ontario – January 12, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and ...
in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
